{"disease":{"id":"advanced-endstage-solid-carcinomas-in-adults","name":"advanced endstage solid carcinomas in adults"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02094560","title":"CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":45,"lead_sponsor_name":"CellAct Pharma GmbH","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}